A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine

Locations

United States

Start date

15/10/2024

Identifiers

Trial ID NN9541-4919,
NCT number NCT06642571,
Eudract number Not Available

Summary

This study will look into a new study medicine called NNC0519-0130 to improve the treatment option for people living with excess body weight or type 2 diabetes or both. The purpose of this study is to compare the amount of NNC0519-0130 in the blood of participants who have excess body weight. The study comprises two parts and the participants will receive both preparations NNC0519-0130 B and NNC0519-0130 C, which treatment the participants get is decided by chance. The study will last for about 24 weeks.

Trial Overview:

Condition

Obesity

Treatment

DRUG: NNC0519-0130 B

DRUG: NNC0519-0130 C

Study type

INTERVENTIONAL

Trial duration

Oct 15 2024 - Apr 22 2025

Participants

Phase

Are you eligible?

Gender

Male and female

Age

18 to 64 years old

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

Find answers in our FAQs

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.